Autophagy inhibition specifically promotes epithelial-mesenchymal transition and invasion in RAS-mutated cancer cells

Macroautophagy/autophagy inhibition is a novel anticancer therapeutic strategy, especially for tumors driven by mutant RAS. Here, we demonstrate that autophagy inhibition in RAS-mutated cells induces epithelial-mesenchymal transition (EMT), which is associated with enhanced tumor invasion. This is a...

Descrizione completa

Dettagli Bibliografici
Autori principali: Wang, Y, Xiong, H, Liu, D, Hill, C, Ertay, A, Li, J, Zou, Y, Miller, P, White, E, Downward, J, Goldin, R, Yuan, X, Lu, X
Natura: Journal article
Pubblicazione: Taylor and Francis 2019
_version_ 1826263457212661760
author Wang, Y
Xiong, H
Liu, D
Hill, C
Ertay, A
Li, J
Zou, Y
Miller, P
White, E
Downward, J
Goldin, R
Yuan, X
Lu, X
author_facet Wang, Y
Xiong, H
Liu, D
Hill, C
Ertay, A
Li, J
Zou, Y
Miller, P
White, E
Downward, J
Goldin, R
Yuan, X
Lu, X
author_sort Wang, Y
collection OXFORD
description Macroautophagy/autophagy inhibition is a novel anticancer therapeutic strategy, especially for tumors driven by mutant RAS. Here, we demonstrate that autophagy inhibition in RAS-mutated cells induces epithelial-mesenchymal transition (EMT), which is associated with enhanced tumor invasion. This is at least partially achieved by triggering the NFKB/NF-κB pathway via SQSTM1/p62. Knockdown of ATG3 or ATG5 increases oncogenic RAS-induced expression of ZEB1 and SNAI2/Snail2, and activates NFKB activity. Depletion of SQSTM1 abolishes the activation of the NFKB pathway induced by autophagy inhibition in RAS-mutated cells. NFKB pathway inhibition by depletion of RELA/p65 blocks this EMT induction. Finally, accumulation of SQSTM1 protein correlates with loss of CDH1/E-cadherin expression in pancreatic adenocarcinoma. Together, we suggest that combining autophagy inhibition with NFKB inhibitors may therefore be necessary to treat RAS-mutated cancer.
first_indexed 2024-03-06T19:52:04Z
format Journal article
id oxford-uuid:244b1ff6-de0f-4537-91df-a667a5c483d0
institution University of Oxford
last_indexed 2024-03-06T19:52:04Z
publishDate 2019
publisher Taylor and Francis
record_format dspace
spelling oxford-uuid:244b1ff6-de0f-4537-91df-a667a5c483d02022-03-26T11:49:15ZAutophagy inhibition specifically promotes epithelial-mesenchymal transition and invasion in RAS-mutated cancer cellsJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:244b1ff6-de0f-4537-91df-a667a5c483d0Symplectic Elements at OxfordTaylor and Francis2019Wang, YXiong, HLiu, DHill, CErtay, ALi, JZou, YMiller, PWhite, EDownward, JGoldin, RYuan, XLu, XMacroautophagy/autophagy inhibition is a novel anticancer therapeutic strategy, especially for tumors driven by mutant RAS. Here, we demonstrate that autophagy inhibition in RAS-mutated cells induces epithelial-mesenchymal transition (EMT), which is associated with enhanced tumor invasion. This is at least partially achieved by triggering the NFKB/NF-κB pathway via SQSTM1/p62. Knockdown of ATG3 or ATG5 increases oncogenic RAS-induced expression of ZEB1 and SNAI2/Snail2, and activates NFKB activity. Depletion of SQSTM1 abolishes the activation of the NFKB pathway induced by autophagy inhibition in RAS-mutated cells. NFKB pathway inhibition by depletion of RELA/p65 blocks this EMT induction. Finally, accumulation of SQSTM1 protein correlates with loss of CDH1/E-cadherin expression in pancreatic adenocarcinoma. Together, we suggest that combining autophagy inhibition with NFKB inhibitors may therefore be necessary to treat RAS-mutated cancer.
spellingShingle Wang, Y
Xiong, H
Liu, D
Hill, C
Ertay, A
Li, J
Zou, Y
Miller, P
White, E
Downward, J
Goldin, R
Yuan, X
Lu, X
Autophagy inhibition specifically promotes epithelial-mesenchymal transition and invasion in RAS-mutated cancer cells
title Autophagy inhibition specifically promotes epithelial-mesenchymal transition and invasion in RAS-mutated cancer cells
title_full Autophagy inhibition specifically promotes epithelial-mesenchymal transition and invasion in RAS-mutated cancer cells
title_fullStr Autophagy inhibition specifically promotes epithelial-mesenchymal transition and invasion in RAS-mutated cancer cells
title_full_unstemmed Autophagy inhibition specifically promotes epithelial-mesenchymal transition and invasion in RAS-mutated cancer cells
title_short Autophagy inhibition specifically promotes epithelial-mesenchymal transition and invasion in RAS-mutated cancer cells
title_sort autophagy inhibition specifically promotes epithelial mesenchymal transition and invasion in ras mutated cancer cells
work_keys_str_mv AT wangy autophagyinhibitionspecificallypromotesepithelialmesenchymaltransitionandinvasioninrasmutatedcancercells
AT xiongh autophagyinhibitionspecificallypromotesepithelialmesenchymaltransitionandinvasioninrasmutatedcancercells
AT liud autophagyinhibitionspecificallypromotesepithelialmesenchymaltransitionandinvasioninrasmutatedcancercells
AT hillc autophagyinhibitionspecificallypromotesepithelialmesenchymaltransitionandinvasioninrasmutatedcancercells
AT ertaya autophagyinhibitionspecificallypromotesepithelialmesenchymaltransitionandinvasioninrasmutatedcancercells
AT lij autophagyinhibitionspecificallypromotesepithelialmesenchymaltransitionandinvasioninrasmutatedcancercells
AT zouy autophagyinhibitionspecificallypromotesepithelialmesenchymaltransitionandinvasioninrasmutatedcancercells
AT millerp autophagyinhibitionspecificallypromotesepithelialmesenchymaltransitionandinvasioninrasmutatedcancercells
AT whitee autophagyinhibitionspecificallypromotesepithelialmesenchymaltransitionandinvasioninrasmutatedcancercells
AT downwardj autophagyinhibitionspecificallypromotesepithelialmesenchymaltransitionandinvasioninrasmutatedcancercells
AT goldinr autophagyinhibitionspecificallypromotesepithelialmesenchymaltransitionandinvasioninrasmutatedcancercells
AT yuanx autophagyinhibitionspecificallypromotesepithelialmesenchymaltransitionandinvasioninrasmutatedcancercells
AT lux autophagyinhibitionspecificallypromotesepithelialmesenchymaltransitionandinvasioninrasmutatedcancercells